Keith T. Flaherty

Venture Partner at Catalio Capital Management

He is a Director of Clinical Research & Richard Saltonstall Chair in Oncology, MGH Cancer Center, Professor of Medicine, Harvard Medical School.


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Catalio Capital Management

Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.


Employees

51-200

Links